Novartis AG vs Sirius XM Holdings Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Sirius XM Holdings Inc trades at $30.27 (market cap $10.30B). The key difference: Novartis AG is far larger — about 28.2× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays the higher dividend (3.53%). Which is the better fit depends on your goals.
| NVS | SIRI | |
|---|---|---|
Market Cap | $290.25B | $10.30B |
Sector | Health | Media |
52-Week High | $168.62 | $31.22 |
52-Week Low | $113.50 | $19.92 |
Enterprise Value | $330.27B | $19.97B |
Dividend Yield | 3.17% | 3.53% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →